Hemoglobin-based blood substitutes and the hazards of blood radicals

References

• Chang T.M.S. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Karger-Landes, Basel 1997; 1
   Google Scholar
• Sloan E.R., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M., Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: A randomized controlled efficacy trial. Journal of American Medical Association 1999; 282: 1857–1864
   PubMed Web of Science ®Google Scholar
• Gulati A., Barve A., Sen A.P. Pharmacology of hemoglobin therapeutics. Journal of Laboratory Clinical Medicine 1999; 133: 112–119
   PubMedGoogle Scholar
• Bleeker W., Agterberg J., La Hey E., Rigter G., Zappeij L., Bakker J. Hemorrhagic disorders after administration of glutaraldehyde-polymerized hemoglobin. Blood Substitutes: New Challenges, R.M. Wislow, K.D. Vandegriff, M. Intaglietta. Birkhauser, Boston, Basel, Berlin 1996; 112–124, In
   Google Scholar
• Mackenzie C.F., Barnas G.M., Christenson R.H., Delaney M.S., Williams J.E., Parr R., Sakamoto R., Alonszana G.L., Trump B.F. Hemostatic and hematological profiles with free hemoglobin solutions following resuscitation from severe hemorrhagic shock in dogs. Anesthesiology 1997; 87: A216–A216
   Google Scholar
• Lee R., Neya K., Svizzero T.A., Vlahakes G.J. Limitations of the efficacy of hemoglobin oxygen carrying solutions. Journal of Applied Physiology 1995; 78: 236–242
   Web of Science ®Google Scholar
• Linberg R., Conover C.D., Shum K.L., Shorr R.G.L. Hemoglobin-based oxygen carriers: how much methemoglobin is too much?. Artificial Cells Blood Substitutes and Immobilized Biotechnology 1998; 26: 133–148
   PubMed Web of Science ®Google Scholar
• Hess J.R. Blood substitutes for surgery and trauma: efficacy and toxicity issues. Biodrugs 1999; 12: 81–91
   PubMed Web of Science ®Google Scholar
• Hess J.R., Macdonald V.W., Brinkley W.W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. Journal of Applied Physiology 1993; 74: 1769–1778
   PubMed Web of Science ®Google Scholar
• Saxena R., Wijnhoud A.D., Carton H., Hacke W., Kaste M., Przybelski R.J., Stern K.N., Koudstaal P.J. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30: 993–996
   PubMed Web of Science ®Google Scholar
• Panter S.S., Regan R.F. Interactions of hemoglobin with central nervous system. Red Blood Cell Substitutes: Basic Principles and Clinical Applications, A.R. Rudolph, R. Rabinovici, G.Z. Feuerstein. Marcel Dekker, New York 1998; 219–234, In
   Google Scholar
• White C.T., Murray A.J., Smith D.J., Greene J.R., Bolin R.B. Synergistic toxicity of endotoxin and hemoglobin. Journal of Laboratory Medicine 1986; 108: 132–137
   PubMed Web of Science ®Google Scholar
• Kaka W., Roth R.I., Levin J. Hemoglobin: a newly recognized lipopolysaccharide (LPS) binding protein which enhances LPS biological activity. Journal of Biological Chemistry 1994; 269: 25078–25084
   PubMedGoogle Scholar
• Kaka W., Roth R.I., Vandegriff K.D., Chen G.C., Kuypers F.A., Winslow R.M., Levin J. Effects of bacterial endotoxin on human cross-linked and native hemoglobins. Biochemistry 1995; 34: 11176–11185
   PubMedGoogle Scholar
• Ketcham E.M., Cairns C.B. Hemoglobin-based oxygen carriers: development and clinical potential. Annals of Emergency Medicine 1999; 33: 326–337
   PubMed Web of Science ®Google Scholar
• Reah G., Bodenham A.R., Mallick A., Dally E.K., Przybelski R.J. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHbTM) as a vasopressor in critically ill patients. Critical Care Medicine 1997; 25: 1480–1488
   PubMed Web of Science ®Google Scholar
• Bunn H.F., Forget B.G. Hemoglobin: Molecular Genetic and Clinical Aspects. W.B. Saunders Co., Philadelphia 1986
   Google Scholar
• Alayash A.I. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nature Biotechnology 1999; 17: 545–549
   PubMed Web of Science ®Google Scholar
• Cashon R.E., Alayash A.I. Reactions of human hemoglobin A0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Archives of Biochemistry and Biophysics 1995; 316: 461–469
   PubMed Web of Science ®Google Scholar
• Alayash A.I., Brockner-Ryan B.A., Eich R.F., Olson J.S., Cashon R.E. Reactions of sperm whale myoglobin with hydrogen peroxide: effects of distal pocket mutations on the formation and stability of the ferryl intermediate. Journal of Biological Chemistry 1999; 274: 2029–2037
   PubMed Web of Science ®Google Scholar
• Dunne J., Svistunenko D.A., Wilson M.T., Alayash A.I., Cooper C.E. Reactions of cross-linked ferric haemoglobins with hydrogen peroxide. Biochemical Society Transactions 1998; 26: S230–S230
   Google Scholar
• Goldman D.W., Breyer R.J., Yeh D., Brockner-Ryan B.A., Alayash A.I. Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron. American Journal of Physiology 1998; 275: H1046–H1053
   PubMed Web of Science ®Google Scholar
• McLeod L., Alayash A.I. Detection of a ferryl intermediate in an endothelial cell model after hypoxia/reoxygenation. American Journal of Physiology 1999; 46: H92–H99
   Google Scholar
• D'Agnillo F., Wood F., Porras C., Macdonald V.W., Alayash A.I. Effects of hypoxia and glutathione depletion on hemoglobin- and myoglobin mediated oxidative stress toward endothelium. Biochimica et Biophysica Acta 2000; 1495: 150–159
   PubMed Web of Science ®Google Scholar
• Moore K.P., Holt S.G., Patel R.P., Svistunenko D.A., Zackert W., Goodier D., Reeder B.J., Clozel M., Anand R., Cooper C.E., Morrow J.D., Wilson M.T., Darley-Usmar V.M., Roberts L.J. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. Journal of Biological Chemistry 1998; 273: 31731–31737
   PubMed Web of Science ®Google Scholar
• Moncada S., Palmer R.M.S., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacology Reviews 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Sharma V.S., Traylor T.G., Gardiner R. Reaction of nitrix oxide with heme proteins and model compounds of hemoglobin. Biochemistry 1987; 26: 3837–3843
   PubMed Web of Science ®Google Scholar
• Eich R.F., Li T., Lemon D.D., Doherty D.H., Curry S.R., Aitken J.F., Matthews A.J., Johnson K.A., Smith R.D., Philips G.N., Olson J.S. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 1996; 35: 6976–6983
   PubMed Web of Science ®Google Scholar
• Alayash A.I., Fratantoni J.C., Bonaventura C., Bonaventura J., Cashon R.E. Nitric oxide binding to human ferrihemoglobins cross-linked between either alpha or beta subunits. Archives of Biochemistry and Biophysics 1993; 303: 332–338
   PubMed Web of Science ®Google Scholar
• Joshi M.S., Ponthier J.L., Lancaster J.R. Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radical Biology and Medicine 1999; 27: 1357–1366
   PubMed Web of Science ®Google Scholar
• Gorbunov N.V., Elsayed N.M., Kisin E.R., Kozlov A.V., Kagan V.E. Air blast-induced pulmonary oxidative stress: interplay among hemoglobin, antioxidants and lipid peroxidation. American Journal of Physiology 1997; 272: L320–L334
   Google Scholar
• Darley-Usmar V.M., Wiseman, Halliwell B. Nitric oxide and oxygen radicals; a question of balance. FEBS Letters 1995; 369: 131–135
   PubMed Web of Science ®Google Scholar
• Alayash A.I., Brockner Ryan B.A., Cashon R.E. Peroxynitrite-mediated heme oxidation and protein modification of native and chemically modified hemoglobins. Archives of Biochemistry and Biophysics 1998; 349: 65–73
   PubMedGoogle Scholar
• Gould S.A., Segal L.R., Seghal H.L., DeWoskin R., Moss G.S. The clinical development of human polymerized hemoglobin. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T.M.S. Chang. Karger-Landes, Basel 1998; II: 12–28, In:
   Google Scholar
• Pearce L.B., Gawryl M.S. Overview of preclinical and clinical efficacy of Biopure's HBOCs. Blood Substitutes: Principles, Methods, Products and Clinical Trials, T.M.S. Chang. Karger-Landes, Basel 1998; Il: 82–98, In:
   Google Scholar
• Liu X., Miller M.J.S., Joshi M.S., Sadowska-Krowicha H., Clark D.A., Lancaster J.R. Diffusion-limited reaction of free nitric oxide with erythrocytes. Journal of Biological Chemistry 1998; 273: 18709–18713
   PubMed Web of Science ®Google Scholar
• Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser H.R., Fratantoni J.C., Alayash A.I. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. Journal of Laboratory Clinical Medicine 1997; 129: 603–610
   PubMedGoogle Scholar
• Kasper S.M., Walter M., Grune F., Walter M., Amr N., Erasmi H., Buzello W. Effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesthesia and Analgesia 1998; 87: 284–291
   PubMed Web of Science ®Google Scholar
• Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnology 1998; 16: 672–676
   PubMed Web of Science ®Google Scholar
• Doyle M.P., Apostol I., Kerwin B.A. Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. Journal of Biological Chemistry 1999; 274: 2583–2591
   PubMedGoogle Scholar
• D'Agnillo F., Chang T.M.S. Polyhemoglobinsuperoxide dismutase-catalase as a blood substitute with antioxidant properties. Nature Biotechnology 1998; 16: 667–672
   PubMed Web of Science ®Google Scholar
• Okayama N., Park J.H., Coe L., Granger D.N., Ma L.I., Hisa C.J.C., Alexander J.S. Polynitroxyl αα-hemoglobin (PNH) inhibits peroxide and superoxidemediated neutrophil adherence to human endothelial cells. Free Radical Research 1999; 31: 53–58
   PubMed Web of Science ®Google Scholar